RankAlpha logo
Back to Rankings

LMAT

LeMaitre VascularC
Nasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
View Chart
Current thesis
Strong Q2 organic growth, Artegraft momentum, higher pricing, mix, operating efficiencies, and substantial cash support a recovery toward the reported $116.25 median target if the guidance reset proves conservative.
Posture
Mixed
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-04 · AMC.
What can break
Catheter sales fell 11% in Q2 due to recall-driven overstocking in the year-ago period.
Momentum
38
Value
55
Sentiment
56
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $88.00 · Bull $105.00 · Bear $65.00Analysis 2026-08-06; returns require an exact persisted reference.
Earnings
2026-11-04 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-28 • Vendor: Data Vendor v1
Scores
As of 2026-10-28 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-06 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-28

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-28. Definitions

Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $107.00
Why
Momentum38 · Δ7d +24.2
Value55 · Δ7d -0.1
Sentiment56 · Δ7d +0.7
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.

Confirming evidence

  • • Next scheduled catalyst: earnings 2026-11-04 · AMC.
  • • Value remains the lead driver in the composite, 7D delta -0.1.

Contradictions & invalidation

  • • Catheter sales fell 11% in Q2 due to recall-driven overstocking in the year-ago period.
  • • Full-year 2026 sales, operating-income, and EPS guidance declined from the prior May outlook.
  • • The full-year guide reduction, Q2 catheter decline tied to recall-driven overstocking, narrower product and customer concentration, and execution demands from international expansion could keep the stock below prior valuation levels.

Catalyst clock

2026-11-04 · AMC

Mixed Q2 print resets the near-term valuation debate

Lead driver: Value · See fundamentals
Momentum
38
8% active weight
Current posture
7d trendFlat
Δ7d
+24.2
Δ21d
+18.7
Value
55
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.6
Sentiment
56
45% active weight
Current posture
7d trendFlat
Δ7d
+0.7
Δ21d
-13.7
Why this grade

Composite grade C. Momentum 37.9 / Value 54.6 / Sentiment 56.2

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-06. Scenario method

B+
Bull case
30%
Probability
Target price
$105.00
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$88.00
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$65.00
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-28
Market Cap
$1.9B
Beta
0.71
Shares Out
22.87M
P/E (TTM)
35.9
P/S (TTM)
7.71
P/FCF (TTM)
37.88
Rev YoY
+9.6%
EPS YoY
+15.5%
Gross Margin
+71.3%
Op Margin
+29.5%
Net Debt
-$173.53M
Current Ratio
15.89
As of 2026-10-28 • Updated nightlySource: Internal modelMethods & Data